Budapest, Hungary

Éva Barabás

This inventor holds 1 USPTO granted patent. Top assignee: Gyogyszerkutato Intezet Kft.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Éva Barabás. Retrieved from https://idiyas.com/inventor/andeacuteva-barabandaacutes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 17.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Éva Barabás

Introduction

Éva Barabás is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticoagulant agents. His work has led to the creation of innovative solutions that have the potential to improve patient care and treatment outcomes.

Latest Patents

Éva Barabás holds a patent for "Anticoagulant peptidyl-arginine aldehyde derivatives." This invention represents a significant advancement in the field of anticoagulant therapies, showcasing his expertise and dedication to medical innovation. He has 1 patent to his name, reflecting his commitment to research and development.

Career Highlights

Barabás is currently associated with Gyogyszerkutato Intezet Kft., a company dedicated to pharmaceutical research. His role at the institute allows him to collaborate with other experts in the field and contribute to groundbreaking research initiatives. His work has been instrumental in advancing the understanding of anticoagulant therapies.

Collaborations

Throughout his career, Éva Barabás has worked alongside esteemed colleagues, including Erzsébet Széll Née Hasenöhrl and András Fehér. These collaborations have enriched his research and expanded the impact of his innovations in the pharmaceutical industry.

Conclusion

Éva Barabás is a distinguished inventor whose work in anticoagulant therapies has made a significant impact in the field of medicine. His dedication to innovation and collaboration continues to drive advancements in pharmaceutical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…